Search results for "proPO"

showing 10 items of 1325 documents

CCDC 614750: Experimental Crystal Structure Determination

2007

Related Article: D.Ballivet-Tkatchenko, H.Chermette, L.Plasseraud, O.Walter|2006|Dalton Trans.||5167|doi:10.1039/b610812a

Space GroupCrystallographybis((mu~2~-Isopropoxo)-(isopropylcarbonato))-tetrakis(n-butyl)-di-tin(iv)Crystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1937786: Experimental Crystal Structure Determination

2019

Related Article: Florian Chotard, Rosita Lapenta, Anaëlle Bolley, Audrey Trommenschlager, Cédric Balan, Jérôme Bayardon, Raluca Malacea-Kabbara, Quentin Bonnin, Ewen Bodio, Hélène Cattey, Philippe Richard, Stefano Milione, Alfonso Grassi, Samuel Dagorne, Pierre Le Gendre|2019|Organometallics|38|4147|doi:10.1021/acs.organomet.9b00501

Space GroupCrystallographybis(mu-isopropoxo)-bis(N'-[(2-oxyphenyl)methyl]-NN-dimethylbenzenecarboximidamide)-di-zincCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 904371: Experimental Crystal Structure Determination

2016

Related Article: Kwang Soo Lim, Shang-Da Jiang, Bong Ho Koo, Dae Won Ryu, Woo Ram Lee, Eui Kwan Koh, José J. Baldoví, Alejandro Gaita-Ariño, Eugenio Coronado, Michael Slota, Lapo Bogani and Chang Seop Hong|2016|CSD Communication|||

Space GroupCrystallographyhexakis(mu-di-isopropoxy(oxo)phosphanyl)-bis(eta5-cyclopentadienyl)-di-cobalt(iii)-dysprosium(iii) hexafluorophosphateCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1826069: Experimental Crystal Structure Determination

2019

Related Article: Nico Röder, Tomasz Marszalek, Daniel Limbach, Wojciech Pisula, Heiner Detert|2019|ChemPhysChem|20|463|doi:10.1002/cphc.201800936

Space GroupCrystallographytetrakis{4-[5-(4-propoxyphenyl)-134-oxadiazol-2-yl]phenyl}pyrazine chloroform solvateCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

FEV1 and FVC predict all-cause mortality independent of cardiac function - Results from the population-based Gutenberg Health Study.

2017

Abstract Background Lung function has previously been related to increased mortality. Whether pulmonary impairment is associated with an increased mortality independent of cardiac dysfunction remains unclear. Methods In 15010 individuals from the general population (age range 35–74years, 51% men) in the Gutenberg Health Study we performed spirometry and transthoracic echocardiography. N-terminal pro-B-type natriuretic peptide (Nt-proBNP) and high-sensitive troponin I (hsTnI) were measured in all individuals. 1819 individuals with pulmonary diseases were excluded from further analysis. Results The median for forced expiratory volume in 1s (FEV1) was 94.2% and for forced vital capacity (FVC) …

SpirometryAdultMalemedicine.medical_specialtyVital capacityPopulationStatistics as TopicVital Capacity030204 cardiovascular system & hematology03 medical and health sciencesFEV1/FVC ratio0302 clinical medicineRisk FactorsInternal medicineCause of DeathForced Expiratory VolumeNatriuretic Peptide BrainmedicineHumansMortalityeducationLungAgedProportional Hazards Modelseducation.field_of_studyCOPDmedicine.diagnostic_testbusiness.industryHazard ratiorespiratory systemMiddle Agedmedicine.diseaseConfidence intervalPeptide Fragmentsrespiratory tract diseases030228 respiratory systemCardiovascular DiseasesEchocardiographyHeart failureCardiologyFemaleCardiology and Cardiovascular MedicinebusinessInternational journal of cardiology
researchProduct

Abstract 13257: FEV1 and FVC predict Mortality in Individuals Without Manifest Lung Disease Independent of Cardiac Performance - Results From the Pop…

2015

Background: Pulmonary disease has consistently been related to increased mortality. We investigated central spirometry variables in relation to total mortality in individuals from the general population without diagnosed lung disease also accounting for cardiac function. Methods: In 15,010 individuals from the general population (mean age 55±11 years, age range 35-74 years, 50.5% men) in the Gutenberg Health Study we performed spirometry and multimodal transthoracic echocardiography. The biomarkers N-terminal pro-B-type natriuretic peptide (Nt-proBNP) and high-sensitive troponin I (TnI) were measured in the first 5000 individuals using commercially available assays. Multivariable Cox regre…

SpirometryVital capacitymedicine.medical_specialtyeducation.field_of_studyEjection fractionmedicine.diagnostic_testProportional hazards modelbusiness.industryPopulationHazard ratiomedicine.diseaseSurgeryFEV1/FVC ratioPhysiology (medical)Internal medicineHeart failuremedicineCardiologyCardiology and Cardiovascular MedicineeducationbusinessCirculation
researchProduct

Note brevi a margine della proposta di riforma dei reati ambientali del gruppo di studio dell'associazione dei professori di diritto penale

2022

A partire dall’analisi della proposta di riforma dei reati contro l’ambiente elaborata dal Gruppo di studio dell’Associazione italiana dei Professori di Diritto Penale, il contributo riflette sui principali problemi teorici del diritto penale ambientale (tipizzazione dell’evento lesivo nelle fattispecie di inquinamento e di disastro ambientale, imputazione soggettiva dei delitti aggravati dall’evento, contrasto penale alle c.d. “ecomafie” nel settore dei rifiuti ecc.), mettendo a confronto le soluzioni suggerite nel testo con le prospettive di riforma contenute nella recente Proposta di Direttiva del Parlamento europeo e del Consiglio sulla Protezione dell’ambiente at- traverso il diritto p…

Starting from the analysis of the proposal for the reform of crimes against the environment drawn up by the Study Group of the Italian Association of Professors of Criminal Law the paper reflects on the main theoretical problems of environmental criminal law (typification of the event in pollution crime and environmental disaster crime mental element of crimes aggravated by the event fight to the so-called “ecomafie” in the waste sector etc.) comparing the solutions suggested in the text with the recent Proposal for a Directive of the European Parliament and of the Council on the Protection of the Environment through Criminal Law that replaces Directive 2008/99.Settore IUS/17 - Diritto Penale
researchProduct

Elasticity as a measure for online determination of remission points in ongoing epidemics.

2020

The correct identification of change-points during ongoing outbreak investigations of infectious diseases is a matter of paramount importance in epidemiology, with major implications for the management of health care resources, public health and, as the COVID-19 pandemic has shown, social live. Onsets, peaks, and inflexion points are some of them. An onset is the moment when the epidemic starts. A "peak" indicates a moment at which the incorporated values, both before and after, are lower: a maximum. The inflexion points identify moments in which the rate of growth of the incorporation of new cases changes intensity. In this study, after interpreting the concept of elasticity of a random va…

Statistics and Probability2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Computer scienceEpidemiology01 natural sciencesTime010104 statistics & probability03 medical and health sciencesRemission induction0302 clinical medicinePandemicHealth careEconometricsHumansComputer Simulation030212 general & internal medicine0101 mathematicsElasticity (economics)EpidemicsPandemicsProportional Hazards Modelsbusiness.industryRemission InductionCOVID-19businessEpidemiologic MethodsRandom variableRate of growthStatistics in medicineREFERENCES
researchProduct

A Log-Rank Test for Equivalence of Two Survivor Functions

1993

We consider a hypothesis testing problem in which the alternative states that the vertical distance between the underlying survivor functions nowhere exceeds some prespecified bound delta0. Under the assumption of proportional hazards, this hypothesis is shown to be (logically) equivalent to the statement [beta[log(1 + epsilon), where beta denotes the regression coefficient associated with the treatment group indicator, and epsilon is a simple strictly increasing function of delta. The testing procedure proposed consists of carrying out in terms of beta (i.e., the standard Cox likelihood estimator of beta) the uniformly most powerful level alpha test for a suitable interval hypothesis about…

Statistics and ProbabilityBiometryGaussianGeneral Biochemistry Genetics and Molecular BiologyCombinatoricssymbols.namesakeNeoplasmsLinear regressionStatisticsChi-square testHumansComputer SimulationCerebellar NeoplasmsChildEquivalence (measure theory)Proportional Hazards ModelsStatistical hypothesis testingMathematicsClinical Trials as TopicGeneral Immunology and MicrobiologyApplied MathematicsEstimatorGeneral MedicineSurvival AnalysisLog-rank testLinear ModelssymbolsGeneral Agricultural and Biological SciencesMedulloblastomaQuantileBiometrics
researchProduct

Marginal hazard ratio estimates in joint frailty models for heart failure trials

2019

Abstract This work is motivated by clinical trials in chronic heart failure disease, where treatment has effects both on morbidity (assessed as recurrent non‐fatal hospitalisations) and on mortality (assessed as cardiovascular death, CV death). Recently, a joint frailty proportional hazards model has been proposed for these kind of efficacy outcomes to account for a potential association between the risk rates for hospital admissions and CV death. However, more often clinical trial results are presented by treatment effect estimates that have been derived from marginal proportional hazards models, that is, a Cox model for mortality and an Andersen–Gill model for recurrent hospitalisations. …

Statistics and ProbabilityBiometryleast false parameterDiseasejoint frailty modelRisk AssessmentStudy durationCardiovascular deathunexplained heterogeneitymedicineHumansTreatment effectComplex Regression ModelsProportional Hazards ModelsHeart FailureClinical Trials as TopicProportional hazards modelbusiness.industryheart failure trialsHazard ratioGeneral Medicinemedicine.diseaseClinical trialrecurrent eventsHeart failureAsymptomatic DiseasesStatistics Probability and UncertaintybusinessDemographyResearch PaperBiometrical Journal. Biometrische Zeitschrift
researchProduct